FDA Approves ADMA Biologics’ Expanded Manufacturing Process for Intravenous Immune Globulin April 29, 2021 Auto Bot News 0 ADMA will now have the ability to produce Bivigam at an expanded capacity with the same manufacturing scale, while using the same equipment, release testing assays, disposables, and labor force.